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ABSTRACT
The activity of the type III inner ring deiodinase (DIII), which
converts T4 and T3 to inactive metabolites, is induced by serum and
growth factors in primary cultures of rat brown adipocytes. The con-
tribution of pretranslational mechanisms to this increase in DIII
activity was examined in the present studies. DIII mRNA is unde-
tectable in differentiated brown adipocytes when cultured in serum-
free medium. However, exposure to epidermal growth factor (EGF),
acidic or basic fibroblast growth factors (aFGF or bFGF) increase DIII
transcript levels. Lesser inductions are found with platelet-derived
growth factor, and insulin-like growth factor I has no effect. Maximal
induction of DIII mRNA is obtained after 9 h of exposure to EGF,
bFGF, or aFGF at a concentration of 10 ng/ml. The increase in DIII
mRNA in response to aFGF, bFGF, and EGF requires gene tran-
scription and protein synthesis, as the inductive effect on mRNA is
completely blocked by actinomycin D or cycloheximide. The DIII
mRNA half-life is 4 h when stimulated with bFGF and increases to
12 h when 10% serum, EGF, or aFGF is present.
In conclusion, EGF, aFGF, and bFGF increase DIII mRNA expres-
sion in differentiated brown adipocytes. This effect appears to be
exerted at the level of both enhanced transcription and mRNA sta-
bilization. (Endocrinology 139: 634–639, 1998)
THE IODOTHYRONINE deiodinases are key enzymesregulating thyroid hormone action in peripheral tissues.
Three different deiodinases have been described, each of which
shows distinctive characteristics, which include substrate spec-
ificity and reaction kinetics, tissue expression patterns, and rel-
ative sensitivity to the inhibitors 6-n-propyl-2-thiouracil and
gold thioglucose and to the factors regulating their activity (1).
The type I and II deiodinases (DI and DII, respectively) catalyze
the conversion of the prohormone T4 to the biologically active
T3 (1). Therefore, DI and DII facilitate thyroid hormone action.
In contrast, the type III deiodinase (DIII) removes iodine from
the inner ring of both T4 and T3, resulting in the formation of
the inactive thyroid hormone analogs rT3 and 3,39-diiodothy-
ronine (2). DIII has been postulated to have an important role
in protecting various tissues from high T3 concentrations, es-
pecially during the early stages of development (3).
DIII activity has been detected in many rat tissues, including
brain (4–6), retina (7), placenta (8), skin (9), intestine, and skel-
etal muscle (10, 11). Expression of this protein is highest in most
of these tissues during development, with levels being low or
undetectable in the adult (5, 12). In addition to these develop-
ment-associated changes, several other factors are known to
regulate DIII activity. Thus, hypothyroidism leads to a decrease
in both brain and skin DIII activity, whereas hyperthyroidism
results in increased DIII activities (9, 13–15). In addition, DIII
activity is strongly induced in certain cell culture systems by
various growth factors and serum components. For example in
rat astroglial cells, several growth factors, including acidic and
basic fibroblast growth factors (aFGF and bFGF), epidermal
growth factor (EGF), and platelet-derived growth factor
(PDGF), as well as phorbol esters (16) and 8-bromo-cAMP (16,
17) are potent inducers of DIII activity.
DIII activity has not been described to be present in brown
adipose tissue (BAT) in vivo. Studies in our laboratory have
recently demonstrated that DIII activity is markedly induced
by serum and several growth factors in primary cultures of
rat brown adipocytes (18). This induction of DIII activity by
specific growth factors may be relevant to the regulatory
control of this enzyme during early development.
Recently, cDNAs coding for the three deiodinases have
been isolated from rat (19–22) and other species (22–25).
Sequences analysis has demonstrated that all of them contain
an in-frame TGA codon that results in the incorporation of
the uncommon amino acid selenocysteine into the peptide
chain during translation (20, 23, 25). These enzymes are
among the few selenocysteine-containing proteins that have
been described in mammals and other eukaryotes (26). In the
present work we have used a rat DIII cDNA probe to study
for the first time the regulation of DIII expression at the
mRNA level by growth factors. Using cultured rat brown
adipocytes as a model system, we demonstrate that several
growth factors induce DIII mRNA levels, an effect most
likely exerted by an increase in transcription.
Materials and Methods
Materials
DMEM was obtained from Life Technologies (Uxbridge, UK). New-
born calf serum (NCS) was purchased from Flow (Paisley, Scotland).
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Antibiotics were obtained from the local pharmacy. BSA (in solution at
22%, pH 7.2) was purchased from Ortho Diagnostic Systems, Johnson &
Johnson Co. (Raritan, NJ). Collagenase, bovine insulin, ascorbic acid,
guanidinium HCl, 3-N-morpholino-propanesulfonic acid (MOPS), di-
thiothreitol, 6-n-propyl-2-thiouracil, T3, norepinephrine, and endothe-
lin-1 were obtained from Sigma Chemical Co. (St. Louis, MO). Agarose
was purchased from FMC Bioproducts (Rockland, ME). Cycloheximide,
actinomycin D, bFGF, aFGF, insulin-like growth factor I (IGF-I), EGF,
and PDGF (B/B homodimer) were obtained from Boehringer Mannheim
(Mannheim, Germany). Unless otherwise specified, aFGF was used in
the presence of 50 mg/ml heparin (final concentration), as recommended
for proper biological activity. Ion exchange resin AG1-X8 was obtained
from Bio-Rad (Richmond, CA). Radiolabeled [a-32P]deoxy-CTP (3000
Ci/mmol) was purchased from Amersham International (Aylesbury,
UK). Formamide was purchased from Fluka (Buchs, Switzerland) or
Merck, and the oligo-labeling system was obtained from Pharmacia
(Uppsala, Sweden). Nytran membranes were purchased from Renner
(Darmstadt, Germany). Charcoal (Norit-A) to prepare hormone-
depleted serum was obtained from Amend (New York, NY).
Cultures of brown adipocytes
Precursor cells were obtained from the interscapular brown adipose
tissue of 20-day-old rats (Sprague-Dawley), isolated according to the
method described by Ne´chad et al. (27) with modifications (28), using
collagenase digestion (0.2%) in DMEM-1.5% BSA at 37 C and filtration
through 250-mm pore size silk filters. Mature cells were allowed to float,
and the infranatant was filtrated through 25-mm pore size silk filters and
centrifuged. A hypoosmotic shock (to remove red blood cells) was not
performed. Precursor cells were seeded in 25-cm2 culture flasks at a
density of 1500–2000 cells/cm2 on day 1 and grown in DMEM supple-
mented with 10% NCS, 3 nm insulin, 10 mm HEPES, 50 IU penicillin, 50
mg streptomycin/ml, and 15 mm ascorbic acid. Culture medium was
changed on day 1 and every second day thereafter until the experiment
was performed. Precursor cells proliferate actively under these condi-
tions, reach confluence on the fourth or fifth day after seeding (40,000–
60,000 cells/cm2), and then differentiate into mature brown adipocytes.
All studies were performed in fully differentiated brown adipocytes (on
the eighth day after seeding).
Both NCS and hypothyroid serum (Hypo serum) were used for cul-
ture. The latter was obtained by depleting NCS of thyroid hormones
with the anion exchange resin AG1X8, as previously described (29).
Hypo serum contained about 10% or less of the original amount of
thyroid hormones, as assessed by RIA (30). In NCS, concentrations of T4
and T3 were 77 and 1.3 nm, respectively. These levels were decreased to
2.2 nm T4 and 0.13 nm T3 in Hypo serum.
RNA preparation and Northern blot analysis
Total cellular RNA was extracted in guanidinium-HCl as previously
described (31), using ethanol precipitation. The recovery was 60–90 mg
total RNA/25-cm2 flasks (containing ;5 3 106 cells). For isolation of
polyadenylated [poly(A)1] RNA, cells were collected, and mRNA was
isolated using oligo(deoxythymidine) cellulose as previously described
(32). For Northern analysis, total RNA (20 mg) or poly(A)1 (5 mg) was
denatured and electrophoresed on a 2.2-m formaldehyde/1% agarose
gel in 1 3 MOPS buffer and transferred to nylon membranes (Nytran)
as previously described (28). A 1100-bp fragment of a rat DIII cDNA
clone (21), corresponding to most of the translated region of the DIII
mRNA, was used as a probe by labeling with [a-32P]deoxy-CTP using
random primers (SA, .108 cpm/mg DNA). Filters were hybridized for
20 h at 50 C [40% formamide, 5 3 SSC (standard saline citrate), 2 3
Denhardt’s, and 0.1% SDS] and washed four times in 2 3 SSC-0.2% SDS
at room temperature for 15 min, then twice in 0.1 3 SSC-0.2% SDS at 65
C for 20 min. Autoradiograms were obtained from the filters and quan-
tified by laser computer-assisted densitometry (Molecular Dynamics,
Sunnyvale, CA). The filters were hybridized with cyclophilin as a control
to correct for differences between lanes in the amount of RNA (33). Some
filters were hybridized with the rat uncoupling protein (UCP) cDNA
(34).
All of the experiments were repeated at least twice, using duplicates,
Northern blot analysis was often performed in both. The more complete
and representative experiments are shown in the figures.
Results
We have recently reported that brown adipocytes differ-
entiated in primary culture are able to express DIII activity
and that this activity is markedly induced by different
growth factors and by serum (18). The increases in DIII
activity are dependent on the dose and exposure time used.
Growth factors increase DIII mRNA levels
We have tested the effects of different growth factors on
DIII mRNA expression in brown adipocytes. Completely
differentiated brown adipocytes were exposed to different
growth factors in serum-free medium for a period that
ranged from 5–18 h. Northern blot analysis showed hybrid-
ization of the DIII probe primarily to a band of approximately
2.2 kilobases (Fig. 1). Basal expression of DIII mRNA was
undetectable in the presence of serum-free medium (Fig. 1A,
control, lanes 11 and 12). A clear induction of DIII mRNA
expression is observed in cells exposed to EGF, aFGF, and
bFGF (Fig. 1, A and B). No induction is observed by IGF-I and
endothelin-1 at the concentrations used in this study. A
smaller induction is observed using transforming growth
factor-b1 (TGFb1; Fig. 2). PDGF did not stimulate DIII
mRNA at a dose of 5 ng/ml (Fig. 1A), but a clear induction
was observed at a dose of 50 ng/ml (Fig. 2).
Dose-response and time-course experiments of DIII mRNA
expression
Figure 3 demonstrates that EGF, aFGF, and bFGF stimulate
expression of DIII mRNA in a dose-dependent fashion, with
FIG. 1. A, Northern analysis demonstrating induction of DIII mRNA
by growth factors in differentiated rat brown adipocytes. Cells were
exposed for 12 h to EGF (10 ng/ml), aFGF (4 ng/ml), IGF-I (1 nM),
PDGF (5 ng/ml), and endothelin-1 (10 nM) in serum-free medium.
Twenty micrograms of total RNA were loaded per lane using dupli-
cates. B, Induction of DIII mRNA by EGF (10 ng/ml for 5 h) in
serum-free medium (left panel). Induction of DIII mRNA by EGF and
bFGF (10 ng/ml and 18 h for both growth factors) in serum-free
medium (right panel). Five micrograms of poly(A)1 RNA were loaded
per lane. A control hybridization with a cyclophilin cDNA probe is also
shown.
DIII mRNA IN BROWN ADIPOCYTES 635
 by on May 11, 2010 endo.endojournals.orgDownloaded from 
maximal induction observed at the highest dose tested (10
ng/ml).
To analyze the time dependency of this induction, cells
were exposed to EGF (10 ng/ml), aFGF (4 ng/ml), and bFGF
(10 ng/ml) for 4, 9, and 24 h. Northern blot analysis (Fig. 4)
showed that maximal induction occurred around 9 h of ex-
posure for the three growth factors tested (maximal induc-
tion is found between 8–12 h). Densitometric analysis reveals
that aFGF is more potent than EGF and bFGF.
DIII mRNA inductions are sensitive to actinomycin D and
cycloheximide
Studies with actinomycin D and cycloheximide were per-
formed to determine the dependence of DIII induction on
transcription and protein synthesis. Cells were exposed for
6 h to aFGF, bFGF, and EGF in the presence or absence of
either actinomycin D or cycloheximide (which were added 15
min before the addition of growth factors). Figure 5 shows
that actinomycin D and cycloheximide completely abolish
the induction of DIII mRNA produced by both aFGF and
bFGF, suggesting that gene transcription and protein syn-
thesis are required for the effects of these agents on DIII
mRNA expression.
DIII mRNA stability
Experiments were performed to determine the stability of
the DIII mRNA. Mature adipocytes, cultured in the presence
of 1% NCS, were exposed to bFGF (10 ng/ml) for 7 h to
stimulate DIII mRNA expression. Cells were then switched
to either serum-free medium or one containing 10% NCS,
Actinomycin D was added, and cells were harvested at vary-
ing times for the preparation of RNA. Northern blot analysis
(Fig. 6A) shows that the presence of serum plays an impor-
tant role in increasing the DIII mRNA stability. In cells cul-
tured in serum-free medium, the DIII mRNA level was mark-
edly reduced after 7 h of exposure to actinomycin D. In
contrast, only a 20% reduction was observed in cells exposed
to 10% serum. Quantitative analysis indicated that the DIII
mRNA half-life was approximately 4 h after induction with
bFGF in the absence of serum and was longer than 12 h when
serum was present.
The effects of EGF and aFGF on DIII mRNA stability were
also examined in cells cultured and maintained in 1% NCS
(Fig. 6B). Basal levels were undetectable (results not shown).
The results demonstrate that, as in the case of serum, EGF
and aFGF significantly prolonged the half-life of this
transcript.
Expression of DIII and UCP mRNAs
Our previous studies demonstrated before that the ex-
pression of UCP, a specific marker for brown fat, is main-
tained in brown adipocytes even in the presence of high DIII
activities (18). To check for the simultaneous expression of
UCP and DIII mRNAs, cells were exposed to different
growth factors, and at the same time T3 and norepinephrine
were added to stimulate UCP mRNA expression. T3 was
added at 5 nm to compensate for the amounts expected to be
degraded by DIII. In Fig. 7 it is shown that after 8 h of
exposure both mRNAs were present in the cells. In other
words, the presence of these growth factors involved in pro-
liferation did not prevent the induction of UCP mRNA ex-
FIG. 2. Induction of DIII mRNA by growth factors. Cultures of dif-
ferentiated brown adipocytes in serum-free medium were exposed to
EGF (10 ng/ml), aFGF (4 ng/ml), bFGF (10 ng/ml), PDGF (50 ng/ml),
or TGFb (10 ng/ml) for 7 h. Twenty micrograms of total RNA were
used per lane for Northern analysis. Hybridization with a cyclophilin
cDNA was used to correct for differences between lanes.
FIG. 3. Dose-dependent induction of DIII mRNA by EGF, aFGF, and
bFGF. Cultures of brown adipocytes were exposed for 12 h to different
doses of EGF, aFGF, and bFGF in serum-free medium. Twenty mi-
crograms of total RNA were used per lane for Northern analysis.
Hybridization with a cyclophilin cDNA was used to correct for dif-
ferences between lanes.
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pression by catecholamines; therefore, there are true brown
adipocytes.
Discussion
The outer and inner ring deiodinases control thyroid hor-
mone action by providing the appropriate T3 concentrations
required for specific functions in a given tissue. These en-
zymes are regulated by a number of hormonal factors, in-
cluding T3 and T4. Other factors regulating DIII activity in-
clude retinoids, growth factors, and phorbol esters (16, 35).
DIII appears to play an important role during mammalian
development, as it is the predominant deiodinase expressed
in the placenta and a number of fetal tissues (5, 7, 10). A
similar expression pattern has been noted in anuran am-
phibians, where DIII expression predominates in the early
stages of development. Later, DII expression becomes prom-
inent during metamorphic climax in those tissues undergo-
ing the most dramatic anatomical restructuring, such as tail,
limbs, and intestine (36). These observations have led to
speculation that DIII serves a protective role in limiting early
fetal exposure to T4 and T3.
We have recently shown that DIII activity can be stimu-
lated in cultured brown adipocytes by serum or a variety of
growth factors in a dose- and time-dependent manner (18).
In the present studies, we further characterized the mecha-
nisms involved in this stimulatory activity. The predominant
2.2-kilobase DIII mRNA species noted in cultured adipocytes
corresponds to that previously reported in neonatal skin,
placenta, and cerebral cortex (21). Furthermore, we observed
that growth factor-induced increases in DIII mRNA levels
accompany the induction of DIII activity in this model cell
culture system. This stimulation is relatively short-lived and
depends on the growth factor added. As is the case of DIII
activity levels (18), EGF and aFGF are the most potent in-
ducers of DIII mRNA (18). For example, aFGF exhibits a
stimulatory effect at 3 ng/ml on both of these parameters,
and its effect is still present after cells have been exposed for
24 h. In the case of less potent agents, such as bFGF, the
stimulatory effects on DIII mRNA wane more quickly. Other
investigators (16) have shown that aFGF and bFGF also stim-
ulate DIII activity in a different model system, primary cul-
tures of rat astroglial cell. It thus appears that DIII is up-
regulated in several cell types by growth factors that act via
tyrosine kinase receptors. The specific signaling pathways
used by EGF or both fibroblast growth factors to increase DIII
transcription are still a matter of speculation, although the erk
cascade has been recently proposed to regulate the induction
of DIII in astroglial cells (37).
The experiments performed in the presence of cyclohex-
imide and actinomycin indicate that DIII mRNA induction
FIG. 4. Time course of induction of DIII mRNA by growth factors.
Cultures of brown adipocytes maintained in medium containing 1%
hypothyroid serum were exposed for 4, 9, or 24 h to EGF (10 ng/ml),
aFGF (4 ng/ml), or bFGF (10 ng/ml). Twenty micrograms of total RNA
were used per lane for Northern analysis. Hybridization with a cy-
clophilin cDNA was used to correct for differences between lanes.
FIG. 5. Effects of actinomycin D and cycloheximide on DIII mRNA.
Cultures of brown adipocytes were exposed for 6 h to aFGF (10 ng/ml),
bFGF (10 ng/ml), or EGF (10 ng/ml) in medium containing 1% hy-
pothyroid serum and actinomycin D (5 mg/ml) or cycloheximide (25
mM). Twenty micrograms of total RNA were used for Northern anal-
ysis. C, Basal expression. Hybridization with a cyclophilin cDNA was
used to correct for differences between lanes.
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by growth factors is activated at the transcriptional level and
is dependent on de novo protein synthesis, suggesting the
need for intermediate proteins for increases in mRNA. We
also performed studies to determine whether the effects of
growth factors on increasing DIII mRNA involve an increase
in the DIII mRNA half-life. Our studies suggest that this may
indeed be the case, as culturing cells in 10% serum signifi-
cantly prolongs transcript half-life, suggesting that some fac-
tors present in serum may regulate DIII mRNA stability.
Although the nature of these factors remains to be estab-
lished, aFGF or EGF are good candidates, as our results
indicate that they both also appear to stabilize DIII mRNA.
The potent effects of growth factors on stimulating DIII in
cultured brown adipocytes contrasts sharply with our ob-
servations that DIII activity is not detectable in BAT from
adult, neonatal, and fetal rats (Hernandez, A., and M. J.
Obregon, unpublished data). Several possible explanations
can be offered for this discrepancy. Firstly, we do not know
whether BAT in vivo is exposed to the concentrations of
growth factors used in these studies. However, these levels
have been commonly used to test for the biological effects of
these agents, and they are within the concentration range
described in biological fluids. Of note, norepinephrine stim-
ulates the expression of bFGF by brown preadipocytes (38),
a effect that may contributes to the hypertrophy of brown fat
during cold adaptation (39). It also appears likely that aFGF,
a potent angiogenic factor, is present in BAT given the highly
vascular nature of this tissue.
Secondly, other factors present in BAT in vivo might sup-
press or counteract the effects of growth factors, preventing
expression of DIII. Thirdly, DIII might be expressed in BAT
either very early in development or, in more mature animals,
only by relatively undifferentiated precursor BAT cells that
are present in such small numbers that activity cannot be
detected in whole tissue homogenates. Expression of DIII in
culture might then result from an enrichment of this popu-
lation of preadipocyte cells during the initial period of our
cell culture protocol. In this sense recent studies from our
group show higher DIII expression in preadipocytes during
proliferative stages and good correlations with mitogenic
activity using the present culture system (40). Finally, in-
duction of DIII expression by growth factors may be asso-
ciated with cells that keep some proliferative capacity, as has
been previously described in cultured hepatocarcinoma cells
(41). We now have evidence that the growth factors tested act
as mitogens for brown fat cells, stimulating DNA synthesis
in vitro in proliferation assays (42). Furthermore, this induc-
tion of DIII by proliferative agents is noteworthy given that
high DIII activities are found early in development when the
rates of cellular proliferation are presumably high.
FIG. 6. Determination of half-life of
DIII mRNA. A, Eight-day-old cultures
of brown adipocytes were exposed to
bFGF (10 ng/ml) for 7 h in medium con-
taining 1% NCS. After 7 h, cells were
washed and switched to serum-free me-
dium or 10% NCS, and then actinomy-
cin D (5 mg/ml) was added. Cells were
harvested at 2, 4, and 6 h. The last two
lanes show results from cells with or
without induction with bFGF. Twenty
micrograms of total RNA were used per
lane for Northern analysis. Hybridiza-
tion with a cyclophilin cDNA was used
to correct for differences between lanes.
B, Eight-day-old cultures of brown adi-
pocytes were exposed to aFGF, EGF, or
bFGF (10 ng/ml for each) for 8 h in me-
dium containing 1% NCS. After 8 h, ac-
tinomycin D (5 mg/ml) was added. Cells
were collected at 2, 4, and 7 h. Twenty
micrograms of total RNA were used per
lane for Northern analysis. Hybridiza-
tion with a cyclophilin cDNA was used
to correct for differences between lanes.
FIG. 7. Effects of growth factors on the adrenergic stimulation of UCP
mRNA. Eight-day-old cultures of brown adipocytes were exposed to
medium containing 0.5% hypothyroid serum and 5 nM T3 for 48 h.
Norepinephrine (NE; 3 mM) and the respective growth factor were
then added during the last 7 h of incubation. Growth factor doses were
5 ng/ml for PDGF, 5 ng/ml for aFGF, and 10 ng/ml for EGF and bFGF.
Positive hybridization with UCP cDNA is shown after treatment with
NE and T3, and hybridization with a cyclophilin cDNA was used to
correct for differences between lanes.
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In an attempt to exclude that DIII activity is present in
other possible “contaminant” cell types in the cultures, we
analyzed DIII activity in primary cultures of aortic endothe-
lial cells and in the fibroblastic cell line 3T3, both stimulated
with serum and growth factors, and using similar number of
cells, we obtained negative results for the presence of DIII
activity. Further studies are needed to localize DIII in brown
adipocytes by in situ hybridization studies in the primary
cultures.
In summary, we have demonstrated that selected growth
factors that act as proliferative agents for brown adipocytes
are potent inducers of DIII mRNA and activity in this cell
type. It will be of interest to determine whether this phe-
nomenon also accompanies mitogenic stimulation for other
cells, and what the physiologic consequences of this induc-
tion are. Such information may provide important insights
into the role of DIII during development.
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